TrialJournal of hematology & oncology2020

Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1.

Meng Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.